Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - MANNKIND CORP | Financial_Report.xls |
EX-32 - EX-32 - MANNKIND CORP | v59490exv32.htm |
EX-31.1 - EX-31.1 - MANNKIND CORP | v59490exv31w1.htm |
EX-10.2 - EX-10.2 - MANNKIND CORP | v59490exv10w2.htm |
EX-10.3 - EX-10.3 - MANNKIND CORP | v59490exv10w3.htm |
EX-31.2 - EX-31.2 - MANNKIND CORP | v59490exv31w2.htm |
10-Q - FORM 10-Q - MANNKIND CORP | v59490e10vq.htm |
Exhibit 3.4
CERTIFICATE OF AMENDMENT OF
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF
MANNKIND CORPORATION
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF
MANNKIND CORPORATION
MannKind Corporation, a corporation organized and existing under and by virtue of the
General Corporation Law of the State of Delaware (the Corporation), does hereby certify:
First: The original name of the Corporation was Pharmaceutical Discovery Corporation.
The date on which the Corporations original Certificate of Incorporation was filed with the
Secretary of State of the State of Delaware is February 14, 1991.
Second: This Certificate of Amendment amends certain provisions of the Amended and
Restated Certificate of Incorporation of the Corporation, as amended (the Restated Certificate),
and has been duly adopted by the Board of Directors of the Corporation acting in accordance with
the provisions of Section 242 of the General Corporation Law of the State of Delaware, and further
adopted in accordance with the provisions of Sections 211 and 242 of the General Corporation Law of
the State of Delaware by the stockholders of the Corporation and shall become effective upon filing
with the Secretary of State of the State of Delaware.
Third: Paragraph A of Article IV of the Restated Certificate is hereby amended and
restated to read in its entirety as follows:
A. This Corporation is authorized to issue two classes of stock to be designated,
respectively, Common Stock and Preferred Stock. The total number of shares which the
Corporation is authorized to issue is two hundred sixty million (260,000,000) shares. Two
hundred fifty million (250,000,000) shares shall be Common Stock, each having a par value
of one cent ($.01). Ten million (10,000,000) shares shall be Preferred Stock, each having a
par value of one cent ($.01).
In Witness Whereof, MannKind Corporation has caused this Certificate of Amendment to
be signed by its Corporate Vice President, General Counsel and Secretary on June 2, 2011.
MannKind Corporation |
||||
By: | /s/ David Thomson | |||
David Thomson | ||||
Corporate Vice President, General Counsel and Secretary |